Company Filing History:
12 out of 525 
6 out of 43 
6 out of 90 
Years Active: 1996-2009
Title: The Innovations of Mark Marchioni
Introduction
Mark Marchioni is a notable inventor based in Arlington, MA (US), recognized for his significant contributions to the field of neuroscience. With a total of 15 patents to his name, he has made remarkable strides in the understanding and treatment of glial cell-related conditions.
Latest Patents
Among his latest patents is the invention titled "Glial mitogenic factors, their preparation and use." This patent discloses the characterization and purification of DNA encoding various polypeptides that are useful for stimulating glial cell mitogenesis, particularly Schwann cells, and for treating glial cell tumors. The patent also includes methods for synthesizing, purifying, and testing both known and novel polypeptides for therapeutic and diagnostic applications in diseases involving glial cells. Another significant patent is the "Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factor." This invention focuses on the prophylaxis or treatment of nervous system pathological conditions through the administration of secretable glial growth factors, such as GGF-2.
Career Highlights
Mark Marchioni has had a distinguished career, working with prominent organizations such as the Ludwig Institute for Cancer Research Limited and Cambridge Neuroscience, Inc. His work has significantly advanced the understanding of glial cells and their role in various neurological conditions.
Collaborations
Throughout his career, Marchioni has collaborated with esteemed colleagues, including Andrew David Goodearl and Paul Stroobant. These collaborations have further enriched his research and innovations in the field.
Conclusion
Mark Marchioni's contributions to neuroscience through his patents and collaborations highlight his dedication to advancing medical science. His work continues to pave the way for new treatments and understanding of glial cell functions.